Diabetes-specific oral nutritional supplement (low-carbohydrate, high-monounsaturated fatty acids)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Diabetes-specific oral nutritional supplement (low-carbohydrate, high-monounsaturated fatty acids), covering 2012-07-02 to 2012-07-02. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients [NA]